Answers are grounded in this paper and cite their sources.
iffuse large B-cell lymphoma (DLBCL) of the lung is a rare entity, and although the prognosis is favorable, its biological features, clinical presentation, prognostic markers, and treatment have not been well defined.1,2 It is the second most common primary pulmonary lymphoma (PPL) after mucosa-associated lymphoid tissue (MALT).PPL itself is very rare; it represents 3%-4% of extranodal non-Hodgkin lymphoma, Ͻ 1% of NHL, and 0.5%-1.0% of primary pulmonary malignancies.2,3 A review of the literature indicates a lack of data on pulmonary DLBCL.The objective of this case report is to highlight areas in which further research may be pursued to better understand this disease. Case presentationA 63-year-old man presented to the emergency department with the complaint of shortness of breath on minimal exertion, chronic nonproductive cough, and worsening left lower chest and flank pain.The shortness of breath had been worsening progressively over the past several months and at the time of presentation it significantly limited his activities of daily living.The chest and flank pain had appeared during the previous week and was described as a constant dull ache.He had a 60 pack year smoking history and his past medical history was significant only for prostate cancer treated with proton beam radiotherapy.Physical examination at the time of initial presentation was remarkable for decreased air entry at the left lung base and mild left-sided lower chest wall tenderness.
No takes yet. Share an insight, caveat, or question.
Minocha et al. (2013) studied this question.
Synapse has enriched 9 related papers. Consider them for comparative context: